| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $420K | -5.0% |
| Cost of Revenue | $42K | +40.0% |
| Gross Profit | $378K | -8.3% |
| R&D Expense | $272K | -42.7% |
| SG&A Expense | $11.3M | -33.7% |
| Operating Income | -$11.2M | +85.6% |
| Pre-tax Income | -$13.5M | +80.9% |
| Income Tax | $3.1M | — |
| Net Income | -$16.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | -19.4% |
| Accounts Receivable | $70K | -48.9% |
| Inventory | $33K | -25.0% |
| Current Assets | $3.3M | -20.9% |
| Total Assets | $27.8M | -9.6% |
| Current Liabilities | $2.1M | -15.7% |
| Total Liabilities | $16.0M | +67.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.3M | +55.0% |
| Capital Expenditures | $67K | -11.8% |
| Investing Cash Flow | -$67K | -9.8% |
| Financing Cash Flow | $8.6M | +3.1% |
| Free Cash Flow | -$9.3M | +54.9% |
| +76.4% |
| EPS (Basic) | -$6.68 | +94.9% |
| Stockholders' Equity |
| $11.8M |
| -44.5% |